At Rise Medical Hub in Madhurawada, Visakhapatnam (Vizag), EECP is a non-invasive symptom-relief option for selected people whose angina continues despite medicines. It is considered when angioplasty or bypass is unsuitable or no further revascularisation option remains.
EECP is not a routine alternative to an indicated stent or bypass. A heart specialist first reviews your symptoms, medicines, coronary anatomy, rhythm, valves, blood pressure, and leg circulation.
Urgent: new, worsening, or resting chest pain needs immediate medical assessment, not an EECP booking.
Scroll through a single treated beat. The ECG sets the timing, the cuffs pressurise from the calves upward once the heart relaxes, and every cuff releases together just before the next contraction.
Three cuff pairs are wrapped around both legs: calves, lower thighs, then upper thighs and buttocks. ECG electrodes on your chest feed the console, which finds the R wave of every beat and works out where systole ends and diastole begins. A finger sensor reads the pressure wave the treatment produces.
During systole the heart ejects into the aorta, and the squeezed heart muscle briefly closes off its own coronary vessels. Nothing is inflated at this moment, because pressure now would only make the heart push harder.
At aortic valve closure (the dicrotic notch), the calf pair pressurises first, then the lower thighs, then the upper thighs and buttocks, roughly fifty milliseconds apart. Squeezing bottom-upward drives blood in the legs back toward a heart that is now relaxed and filling.
That returning wave lifts aortic pressure at the exact moment the coronary arteries fill, and more blood arrives back at the heart for the next beat. On the pressure trace it shows as a diastolic peak that can rise above the systolic one, and the team tunes timing by watching that D/S ratio.
Deflation is simultaneous and fast, timed ahead of the next R wave. The leg vessels empty, resistance falls, and the next contraction meets less afterload. The ECG itself is unchanged. It is the input, not the result. What changes is the pressure the heart works against.
The console re-reads the ECG beat after beat and shifts inflation and deflation as your rhythm changes. A commonly used course is 35 sessions of about an hour, with rhythm, blood pressure, symptoms, and cuff comfort checked throughout.
By increasing pressure while the heart relaxes and releasing before the next contraction, EECP may support blood flow and vascular function across a treatment course. Response varies, and the therapy does not remove plaque or open a blocked artery.
A commonly used course is 35 approximately one-hour sessions, usually five days a week for about seven weeks. The schedule and treatment plan are confirmed for the individual patient.
Symptoms, blood pressure, rhythm, skin comfort, activity tolerance, and short-acting nitrate use can be reviewed along the way. A response is recorded, not assumed.
The team checks how you feel, prepares the skin and monitoring leads, wraps the cuffs, and confirms the plan for the day.
The machine follows the ECG while the team checks cuff timing, pressure, rhythm, blood pressure, symptoms, and comfort.
The cuffs and sensors come off, symptoms and skin comfort are checked, and your response is added to the course record.
Most people leave after the session and return to their day if clinically well. Follow the preparation and activity guidance given by your own treatment team.
Compare centres by the suitability assessment, the responsible clinician, session monitoring, how progress is recorded, and a written estimate for the complete course. Ask what happens if symptoms worsen and how follow-up is arranged. A claim of being the best is not enough to establish that EECP is appropriate for you.
EECP stands for Enhanced External Counterpulsation. ECG-timed cuffs around the legs inflate while the heart relaxes and release before the next contraction. It is a non-invasive, outpatient treatment considered for symptom relief in selected chronic refractory angina.
Rise Medical Hub offers EECP suitability reviews in Madhurawada, Visakhapatnam, also known as Vizag. Contact our team to confirm the appointment, treatment availability and the reports to bring before travelling.
A commonly used EECP course is 35 one-hour sessions over roughly seven weeks. The treating clinician confirms the schedule, whether interruptions are appropriate and how symptoms and treatment response will be monitored.
Ask Rise Medical Hub for a current written estimate after your suitability review. Confirm the planned number of sessions, consultation and test charges, what is included, and any follow-up costs. Insurance or reimbursement eligibility must be checked with your insurer; coverage is not assumed.
Most people describe a strong, rhythmic squeeze rather than pain. Tell the team immediately about pain, numbness, skin irritation, bruising, or any new symptom so the fit, pressure, and session can be reviewed.
A trained clinical team sets up the cuffs and ECG, checks timing and pressure, and monitors symptoms, blood pressure, rhythm, and comfort. The exact staffing and escalation plan are confirmed during your suitability review.
Follow the instructions from your treatment team. Comfortable fitted clothing is commonly recommended. Advice about medicines, meals, hydration, and activity should come from the clinician who knows your history.
Do not stop or change heart medicines for EECP unless your treating clinician specifically tells you to. Medicines and risk-factor treatment usually continue throughout the course.
The team compares angina frequency, short-acting nitrate use, walking or activity tolerance, and your own symptom goals with the baseline recorded before treatment. Improvement is assessed individually rather than promised by a particular week.
Not when revascularisation is indicated and suitable. Angioplasty and bypass directly treat coronary anatomy; EECP is a symptom-relief option considered for selected refractory angina when other suitable treatment options are unavailable.
Tell the team immediately. New chest pain, marked breathlessness, faintness, palpitations, leg pain, or other concerning symptoms need prompt clinical assessment and may require the session to stop.
If you are comparing EECP treatment centres in India or looking for an option in Vizag, start with suitability, the responsible clinician, monitoring and follow-up. Ask for a written estimate for the complete course and include travel if you are coming from another city.
Questions to ask when choosing an EECP centre in India ↗A clinical review at Rise Medical Hub in Madhurawada, Visakhapatnam, comes before any treatment decision. Explore our heart-care consultations in Vizag for help planning the next step.
Find Rise Medical Hub on Google Maps ↗These links include a professional guideline, regulatory and coverage records, controlled trials, registries, and evidence reviews. They are different kinds of evidence and should not be treated as equally conclusive.
Specific external counterpulsation devices have US FDA 510(k) clearance. Clearance means the reviewed device was found substantially equivalent to a predicate device; it is not a guarantee of clinical benefit. The 2023 AHA/ACC guideline gives EECP a Class 2b recommendation: it may be considered for symptom relief in refractory angina when no other treatment options remain. These US regulatory and coverage records do not establish Indian approval, local coverage, or suitability for an individual patient.
Places EECP within the broader care pathway for chronic coronary disease and refractory angina, not as a universal replacement for medicines or revascularisation.
The device-specific record describing intended use, operation, and reviewed indications. Clearance should not be read as a promise of benefit for every patient.
The landmark randomised, sham-controlled trial in refractory angina. Journal of the American College of Cardiology (Arora et al.).
An important counterweight: it found the controlled evidence insufficient for firm conclusions and documented uncertainty around long-term benefit and adverse events.
The US Medicare national coverage decision describes specialist selection, disabling refractory angina, and the usual 35-session schedule.
A plain-language review of how EECP works, who it helps, and what the evidence shows. Clinical Medicine & Research (Sharma, Ramsey, Tak).
A small randomised controlled trial that measured collateral function directly. Useful evidence for a possible mechanism, but not proof that every patient grows a new bypass.
A randomised, controlled trial in stable heart failure with reduced pumping strength. Journal of the American College of Cardiology (Feldman et al.).
Real-world outcomes tracked well beyond the treatment course, from the International EECP Patient Registry (IEPR).
A meta-analysis of 17 studies, useful for reviewing symptom and exercise outcomes while noting the authors' call for larger controlled trials.
Sources checked 17 July 2026. Links open the original publishers, including the American Heart Association, US FDA, CMS, PubMed, and PubMed Central. Rise is not affiliated with them. This page is general education, not a diagnosis, guarantee, or substitute for advice from your own cardiologist.
Choose which cookies we may use. Essential cookies are always on because the site can’t function without them. You can change this anytime from the footer.
_ga / _ga_* cookies.